{"id":"W1986691999","doi":"10.1016/s1098-3015(10)70208-4","title":"PCN30 COSTS RELATED TO ADVERSE EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Tyrosine kinase; Medicine; Adverse effect; Tyrosine-kinase inhibitor; Oncology; Internal medicine; Cancer research; Pharmacology; Cancer; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003440042,0.0002040862,0.0003872285,0.001119819,0.001319788,0.001220461,0.0007483705,0.0005172476,0.003776728],"category_scores_gemma":[0.003613442,0.0002374389,0.0008335905,0.003200082,0.0004250525,0.0002719108,0.000594913,0.001109081,0.0001339495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05207903,"about_ca_system_score_gemma":0.04351315,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.990625,"about_ca_topic_score_gemma":0.9940069,"domain_scores_codex":[0.9988921,0.0001335241,0.00008293291,0.00007143158,0.0003826452,0.0004374417],"domain_scores_gemma":[0.9959417,0.0003220361,0.001084655,0.00002886433,0.001324291,0.001298389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005326981,0.0000753481,0.9731568,0.0001098281,0.000192204,0.0004345235,0.0002210449,0.001594176,0.000129419,0.0009581465,0.007792087,0.01480378],"study_design_scores_gemma":[0.00007100382,0.00005153961,0.9944171,0.00006182476,0.0000762432,0.0002110834,0.0005319916,0.001237819,0.00005894771,0.0001178592,0.00314993,0.00001472382],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9652479,0.004097189,0.0001354688,0.005964155,0.00008241144,0.00008718357,0.01222187,0.00001646063,0.01214742],"genre_scores_gemma":[0.9931499,0.0019387,0.0001043842,0.0005594803,0.00004054888,0.00001742918,0.002310887,0.000005521491,0.001873042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05207903,"threshold_uncertainty_score":0.3778615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01433573690087555,"score_gpt":0.2454023561715701,"score_spread":0.2310666192706946,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}